Millennium Management »

Actuate Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $148k 97k 1.53
2025-03-31 $83k 12k 6.77

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf Call Option (IWM)
Ishares Tr Core S&p500 Etf (IVV)
Astrazeneca Ord Put Option (AZN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation Put Option (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Micron Technology Put Option (MU)
Microsoft Corporation Call Option (MSFT)
Amazon Put Option (AMZN)
Advanced Micro Devices (AMD)
Apple (AAPL)
Meta Platforms Cl A Put Option (META)
Space Exploration Techn Corp Class A Com Stk Call Option (SPCX)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Tesla Motors Call Option (TSLA)

View all positions for Millennium Management

Top funds holding Actuate Therapeutics

BIOS Capital Management
Voss Capital
Vanguard Capital Management
AQR Capital Management
Geode Capital Management
Texas Capital Bank Wealth Management Services
Palogic Value Management
Millennium Management
BlackRock
ABS Direct Equity Fund
ABS Investment Management
State Street Corporation
Vanguard Fiduciary Trust
Rock Creek Group
Jane Street

View all funds holding Actuate Therapeutics